Nurix Therapeutics, Inc. (NRIX) quarterly cash flow statement — complete operating, investing & financing history
Nurix Therapeutics, Inc. (NRIX) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -96.57M | -71.91M | -67.83M | -57.38M | -63.16M | -61.09M | -48.75M | -42.18M | -39.7M | -41.95M | 26.69M | -41.13M | -18.47M | -48.45M | -37.95M | -46.31M | -32.91M | -42.63M | -30.91M | -29.97M |
| Operating CF Margin % | -1067.93% | -1150.26% | -499.61% | -726.94% | -143.37% | -331.04% | -366.99% | -335.06% | -328.36% | -252.95% | 176.06% | -222.74% | -60.21% | -381.96% | -559.56% | -429.14% | -287.91% | -443.09% | -417.94% | -292.35% |
| Operating CF Growth % | -52.9% | -17.72% | -39.14% | -36.06% | -59.08% | -45.62% | -282.66% | -2.54% | -114.98% | 13.42% | 170.32% | 11.18% | 43.89% | -13.66% | -22.79% | -54.5% | -4.37% | -629.37% | -50.92% | -388.06% |
| Net Income | -89.53M | -87.17M | -78.22M | -86.42M | -43.46M | -56.35M | -58.55M | -48.96M | -44.55M | -41.52M | -41.96M | -36.98M | -24.28M | -40.73M | -46.72M | -45.71M | -45.4M | -42.53M | -37.7M | -28.84M |
| Depreciation & Amortization | 3.85M | 3.78M | 4.63M | 5M | 5.1M | 4.13M | 4.3M | 4.15M | 4.09M | 3.89M | 3.76M | 3.38M | 3.33M | 3.18M | 3.04M | 2.89M | 2.63M | 2.25M | 4.05M | 745K |
| Stock-Based Compensation | 11.39M | 9.4M | 9.09M | 9.77M | 10.38M | 8.72M | 8.51M | 8.75M | 8.85M | 7.82M | 8.02M | 8.45M | 8.72M | 8.48M | 8.3M | 6.99M | 6.78M | 6.07M | 4.84M | 4.31M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 930K | -8.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -18.38M | -1.82M | -1.78M | -2.2M | -2.7M | -3.56M | -3.46M | -3.42M | -2.16M | -2.86M | 11.87M | -1.2M | -950K | -762K | -650K | 83K | 661K | 542K | 606K | 662K |
| Working Capital Changes | -3.9M | 3.9M | -1.55M | 16.46M | -32.48M | -14.03M | 449K | -2.7M | -5.94M | -10.21M | 53.88M | -14.78M | -5.3M | -18.62M | -1.92M | -10.56M | 2.42M | -8.96M | -2.71M | -6.86M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | -2M | 0 | 0 | 6M | 0 | 8M | -2M | -6M | 475K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.88M | 4.88M | 0 | 0 | 0 | 0 | -8M | 0 | 3.83M | 0 |
| Change in Payables | 1.87M | -461K | 3.02M | 2.23M | -2.68M | -3.21M | 7.58M | 1.09M | -2.54M | -930K | 4.65M | -1.2M | -2.24M | 400K | -899K | -763K | 1.85M | -103K | 862K | -1.39M |
| Cash from Investing | 93M | -123.83M | 346K | 50.48M | 71.5M | 25.53M | -140.82M | -21.34M | -131.07M | 35.51M | -14.37M | 22.77M | 43.83M | 16.07M | 55.01M | -63.08M | -4.76M | 40.03M | -36.52M | -12.23M |
| Capital Expenditures | -1.94M | -1.04M | -5.13M | -2.71M | -2.67M | -3.48M | -2.1M | -2.35M | -1.94M | -2.88M | -2.58M | -2.46M | -1.08M | -2.28M | -2.56M | -3.42M | -2.79M | -3.47M | -862K | -1.86M |
| CapEx % of Revenue | 21.41% | 16.71% | 37.79% | 34.34% | 6.07% | 18.89% | 15.85% | 18.64% | 16.02% | 17.39% | 17.05% | 13.32% | 3.52% | 17.95% | 37.82% | 31.67% | 24.4% | 36.09% | 11.65% | 18.19% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38.4M | 0 | -38.4M | 88.49M | -25.23M | -44.91M | -18.34M | -57.57M | 59.66M | 1.98M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.4M | 0 | 38.4M | -88.49M | 25.23M | 44.91M | 18.34M | 57.57M | -59.66M | -1.98M | 0 | 0 | 0 |
| Cash from Financing | 66K | 19.98M | 236.01M | 1.16M | 6K | 1.47M | 200.52M | 45.77M | 237.75M | 1.62M | 7K | 1.7M | 25K | 1.48M | -135K | 115.41M | 432K | 1.49M | 500K | 1.55M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 66K | 19.98M | 236.01M | 1.16M | 6K | 1.47M | 199.07M | 41.87M | 237.75M | 1.62M | 7K | 1.7M | 25K | 1.48M | -135K | 19.4M | 432K | 1.49M | 500K | 1.55M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15K | -15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 1.45M | 3.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 96.01M | 0 | 0 | 0 | 0 |
| Net Change in Cash | -3.51M | -175.76M | 168.52M | -5.75M | 8.34M | -34.08M | 10.95M | -17.75M | 66.98M | -4.81M | 12.32M | -16.65M | 25.39M | -30.9M | 16.92M | 6.02M | -37.25M | -1.11M | -66.93M | -40.65M |
| Free Cash Flow | -98.51M | -72.96M | -72.96M | -60.1M | -65.84M | -64.57M | -50.86M | -44.52M | -41.64M | -44.84M | 24.1M | -43.59M | -19.55M | -50.73M | -40.52M | -49.73M | -35.7M | -46.1M | -31.77M | -31.84M |
| FCF Margin % | -1089.34% | -1166.97% | -537.4% | -761.29% | -149.44% | -349.93% | -382.84% | -353.7% | -344.38% | -270.33% | 159.01% | -236.05% | -63.73% | -399.91% | -597.38% | -460.81% | -312.31% | -479.18% | -429.6% | -310.54% |
| FCF Growth % | -49.63% | -12.99% | -43.47% | -34.97% | -58.1% | -44.02% | -310.99% | -2.14% | -113.01% | 11.62% | 159.49% | 12.34% | 45.25% | -10.04% | -27.53% | -56.19% | -6.18% | -739.42% | -48.56% | -307.59% |
| FCF per Share | -0.89 | -0.66 | -0.77 | -0.71 | -0.78 | -0.77 | -0.65 | -0.61 | -0.67 | -0.82 | 0.44 | -0.80 | -0.36 | -0.94 | -0.75 | -0.98 | -0.80 | -1.03 | -0.71 | -0.72 |
| FCF Conversion (FCF/Net Income) | 1.08x | 0.82x | 0.87x | 0.66x | 1.45x | 1.08x | 0.83x | 0.86x | 0.89x | 1.01x | -0.64x | 1.11x | 0.76x | 1.19x | 0.81x | 1.01x | 0.72x | 1.00x | 0.82x | 1.04x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |